These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 15066940

  • 1. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent.
    Botnar RM, Perez AS, Witte S, Wiethoff AJ, Laredo J, Hamilton J, Quist W, Parsons EC, Vaidya A, Kolodziej A, Barrett JA, Graham PB, Weisskoff RM, Manning WJ, Johnstone MT.
    Circulation; 2004 Apr 27; 109(16):2023-9. PubMed ID: 15066940
    [Abstract] [Full Text] [Related]

  • 2. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent.
    Sirol M, Fuster V, Badimon JJ, Fallon JT, Moreno PR, Toussaint JF, Fayad ZA.
    Circulation; 2005 Sep 13; 112(11):1594-600. PubMed ID: 16145001
    [Abstract] [Full Text] [Related]

  • 3. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.
    Botnar RM, Buecker A, Wiethoff AJ, Parsons EC, Katoh M, Katsimaglis G, Weisskoff RM, Lauffer RB, Graham PB, Gunther RW, Manning WJ, Spuentrup E.
    Circulation; 2004 Sep 14; 110(11):1463-6. PubMed ID: 15238457
    [Abstract] [Full Text] [Related]

  • 4. Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging.
    Sirol M, Aguinaldo JG, Graham PB, Weisskoff R, Lauffer R, Mizsei G, Chereshnev I, Fallon JT, Reis E, Fuster V, Toussaint JF, Fayad ZA.
    Atherosclerosis; 2005 Sep 14; 182(1):79-85. PubMed ID: 16115477
    [Abstract] [Full Text] [Related]

  • 5. In vivo optical coherence tomography of experimental thrombosis in a rabbit carotid model.
    Meng L, Lv B, Zhang S, Yv B.
    Heart; 2008 Jun 14; 94(6):777-80. PubMed ID: 17947363
    [Abstract] [Full Text] [Related]

  • 6. Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model.
    Abela GS, Picon PD, Friedl SE, Gebara OC, Miyamoto A, Federman M, Tofler GH, Muller JE.
    Circulation; 1995 Feb 01; 91(3):776-84. PubMed ID: 7828306
    [Abstract] [Full Text] [Related]

  • 7. MRI of atherothrombosis associated with plaque rupture.
    Viereck J, Ruberg FL, Qiao Y, Perez AS, Detwiller K, Johnstone M, Hamilton JA.
    Arterioscler Thromb Vasc Biol; 2005 Jan 01; 25(1):240-5. PubMed ID: 15528478
    [Abstract] [Full Text] [Related]

  • 8. In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model.
    Johnstone MT, Botnar RM, Perez AS, Stewart R, Quist WC, Hamilton JA, Manning WJ.
    Arterioscler Thromb Vasc Biol; 2001 Sep 01; 21(9):1556-60. PubMed ID: 11557688
    [Abstract] [Full Text] [Related]

  • 9. An animal model of atherosclerotic plaque disruption and thrombosis in rabbit using pharmacological triggering to plaques induced by perivascular collar placement.
    Sun X, Cao W, Cui J, Wang L, Ma L, Wang T, Peng C, Tian Z, Shi S, Guo S, Tian Y.
    Cardiovasc Pathol; 2013 Sep 01; 22(4):264-9. PubMed ID: 23452613
    [Abstract] [Full Text] [Related]

  • 10. In vivo MR imaging of plaque disruption and thrombus formation in an atherosclerotic rabbit model.
    Ma X, Zhao Q, Zhao L, Shang J, Feng T, Zeng C, Zhang Z.
    Int J Cardiovasc Imaging; 2012 Mar 01; 28(3):577-86. PubMed ID: 21461662
    [Abstract] [Full Text] [Related]

  • 11. Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.
    Vymazal J, Spuentrup E, Cardenas-Molina G, Wiethoff AJ, Hartmann MG, Caravan P, Parsons EC.
    Invest Radiol; 2009 Nov 01; 44(11):697-704. PubMed ID: 19809344
    [Abstract] [Full Text] [Related]

  • 12. Magnetic resonance imaging features of vulnerable plaques in an atherosclerotic rabbit model.
    Zhao XC, Zhao QM, Ma XH, Zeng CH, Feng TT, Zhao X, Zhang ZQ, Zhang MD, Zhuang XC.
    Chin Med J (Engl); 2013 Nov 01; 126(11):2163-7. PubMed ID: 23769577
    [Abstract] [Full Text] [Related]

  • 13. Increased Vascular Permeability Measured With an Albumin-Binding Magnetic Resonance Contrast Agent Is a Surrogate Marker of Rupture-Prone Atherosclerotic Plaque.
    Phinikaridou A, Andia ME, Lavin B, Smith A, Saha P, Botnar RM.
    Circ Cardiovasc Imaging; 2016 Dec 01; 9(12):. PubMed ID: 27940955
    [Abstract] [Full Text] [Related]

  • 14. Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasmin-based contrast agent.
    Miserus RJ, Herías MV, Prinzen L, Lobbes MB, Van Suylen RJ, Dirksen A, Hackeng TM, Heemskerk JW, van Engelshoven JM, Daemen MJ, van Zandvoort MA, Heeneman S, Kooi ME.
    JACC Cardiovasc Imaging; 2009 Aug 01; 2(8):987-96. PubMed ID: 19679287
    [Abstract] [Full Text] [Related]

  • 15. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent.
    Spuentrup E, Buecker A, Katoh M, Wiethoff AJ, Parsons EC, Botnar RM, Weisskoff RM, Graham PB, Manning WJ, Günther RW.
    Circulation; 2005 Mar 22; 111(11):1377-82. PubMed ID: 15738354
    [Abstract] [Full Text] [Related]

  • 16. Establishing an animal model of unstable atherosclerotic plaques.
    Chen WQ, Zhang Y, Zhang M, Ji XP, Yin Y, Zhu YF.
    Chin Med J (Engl); 2004 Sep 22; 117(9):1293-8. PubMed ID: 15377416
    [Abstract] [Full Text] [Related]

  • 17. EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus.
    Overoye-Chan K, Koerner S, Looby RJ, Kolodziej AF, Zech SG, Deng Q, Chasse JM, McMurry TJ, Caravan P.
    J Am Chem Soc; 2008 May 07; 130(18):6025-39. PubMed ID: 18393503
    [Abstract] [Full Text] [Related]

  • 18. In vivo detection of vulnerable atherosclerotic plaque by MRI in a rabbit model.
    Phinikaridou A, Ruberg FL, Hallock KJ, Qiao Y, Hua N, Viereck J, Hamilton JA.
    Circ Cardiovasc Imaging; 2010 May 07; 3(3):323-32. PubMed ID: 20194634
    [Abstract] [Full Text] [Related]

  • 19. Molecular MRI of cerebral venous sinus thrombosis using a new fibrin-specific MR contrast agent.
    Stracke CP, Katoh M, Wiethoff AJ, Parsons EC, Spangenberg P, Spüntrup E.
    Stroke; 2007 May 07; 38(5):1476-81. PubMed ID: 17379818
    [Abstract] [Full Text] [Related]

  • 20. Molecular coronary MR imaging of human thrombi using EP-2104R, a fibrin-targeted contrast agent: experimental study in a swine model.
    Spuentrup E, Katoh M, Wiethoff AJ, Buecker A, Botnar RM, Parsons EC, Guenther RW.
    Rofo; 2007 Nov 07; 179(11):1166-73. PubMed ID: 17948194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.